Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Wuhan General Group (China) Inc WUHN

Healthcare Drug Manufacturers - Specialty & Generic
Wuhan General Group (China) Inc is a South Africa-based bioceutical company. The Company is focused on alternative plant-based cannabinoids and mental health therapeutic research. Through its subsidiary, Neur.ai, the Company is engaged in developing a portfolio of receptor agonists based on neurotransformational medicine for the treatment of mental illness. The Company develops and... see more

Recent & Breaking News (GREY:WUHN)

Wuhan General Group China Announces Corporate Update

Accesswire May 17, 2022

Dr AnnaRx Announces Rob Simbowe CBD Muscle and Joint Rubs

Accesswire March 30, 2022

Medspresso and Liviana Carried by 100 Independent South African Retailers

Accesswire March 28, 2022

M2Bio Sciences Attending Master Investor Show in London, UK

Accesswire March 16, 2022

M2Bio Labs Offers Ketamine IV & Personalized Supercharged Vitamin IV Drip

Accesswire March 10, 2022

Medspresso Joins the Speciality Coffee Association of South Africa

Accesswire February 28, 2022

Medspresso Launches CBD and Functional Mushroom Single Serve Sachets

Accesswire February 1, 2022

Wuhan General Group Launches Mental Illness Drug Discovery Company Neurai Life Sciences

Accesswire January 19, 2022

M2Bio Rolls Out Sustainable Packaging for Liviana

Accesswire December 31, 2021

M2Bio Director of Health and Fitness Rob Simbowe Visits Zambia and Hosts Vulnerable Youth Symposium

Accesswire December 16, 2021

Wuhan Acquires Remaining Shares in Tsime

Accesswire December 8, 2021

Medspresso Coffee Webinar Now Available for Viewing

Accesswire December 7, 2021

Wuhan General Group Inc Cancels 5,000,000 Common Shares

Accesswire November 22, 2021

The New Multi Capsule "Medspresso Torro" Gets Unleashed

Accesswire November 4, 2021

Medspress(TM) Announces Webinar: The Art, Craft, and Science of Coffee

Accesswire November 1, 2021

M2Bio Building A World Class Supply Chain Solution - Dr. Southey and Dr. Zarrebini Update on M2Bio Blockchain and Technology Group

Accesswire October 25, 2021

The Future Of Personalized Medicine For Mental Illness by Dr. Riyad Domingo

Accesswire September 23, 2021

Medspresso Announces Additional Speciality Coffees To The Range

Accesswire September 17, 2021

M2Bio Sciences Appoints Dr. Riyad Domingo as Chief Innovation Officer

Accesswire September 2, 2021

Dr. AnnaRx(TM) Launching CBD & CBN Nutraceutical Line

Accesswire August 24, 2021